Is aggregated synthetic amorphous silica toxicologically relevant?

BackgroundThe regulatory definition(s) of nanomaterials (NMs) frequently uses the term ‘agglomerates and aggregates’ (AA) despite the paucity of evidence that AA are significantly relevant from a nanotoxicological perspective. This knowledge gap greatly affects the safety assessment and regulation of NMs, such as synthetic amorphous silica (SAS). SAS is used in a large panel of industrial applications. They are primarily produced as nano-sized particles (1–100 nm in diameter) and considered safe as they form large aggregates (> 100 nm) during the production process. So far, it is indeed believed that large aggregates represent a weaker hazard compared to their nano counterpart. Thus, we assessed the impact of SAS aggregation on in vitro cytotoxicity/biological activity to address the toxicological relevance of aggregates of different sizes.ResultsWe used a precipitated SAS dispersed by different methods, generating 4 ad-hoc suspensions with different aggregate size distributions. Their effect on cell metabolic activity, cell viability, epithelial barrier integrity, total glutathione content and, IL-8 and IL-6 secretion were investigated after 24 h exposure in human bronchial epithelial (HBE), colon epithelial (Caco2) and monocytic cells (THP-1). We observed that the de-aggregated suspension (DE-AGGR), predominantly composed of nano-sized aggregates, induced stronger effects in all the cell lines than the aggregated suspension (AGGR). We then compared DE-AGGR with 2 suspensions fractionated from AGGR: the precipitated fraction (PREC) and the supernatant fraction (SuperN). Very large aggregates in PREC were found to be the least cytotoxic/biologically active compared to other suspensions. SuperN, which contains aggregates larger in size (> 100 nm) than in DE-AGGR but smaller than PREC, exhibited similar activity as DE-AGGR.ConclusionOverall, aggregation resulted in reduced toxicological activity of SAS. However, when comparing aggregates of different sizes, it appeared that aggregates > 100 nm were not necessarily less cytotoxic than their nano-sized counterparts. This study suggests that aggregates of SAS are toxicologically relevant for the definition of NMs.

[1]  Philip Demokritou,et al.  Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials , 2017, Nature Protocols.

[2]  Paul Tobback,et al.  Re‐evaluation of silicon dioxide (E 551) as a food additive , 2018, EFSA journal. European Food Safety Authority.

[3]  M. Radomski,et al.  Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects , 2011, International journal of nanomedicine.

[4]  L. Godderis,et al.  Toxicology of silica nanoparticles: an update , 2017, Archives of Toxicology.

[5]  W. D. de Jong,et al.  Novel insights into the risk assessment of the nanomaterial synthetic amorphous silica, additive E551, in food , 2015, Nanotoxicology.

[6]  Jing Yuan,et al.  Associations between Th17-related inflammatory cytokines and asthma in adults: A Case-Control Study , 2017, Scientific Reports.

[7]  Bengt Fadeel,et al.  Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release , 2014, Particle and Fibre Toxicology.

[8]  Yves Van der Stede,et al.  Quantitative characterization of agglomerates and aggregates of pyrogenic and precipitated amorphous silica nanomaterials by transmission electron microscopy , 2012, Journal of Nanobiotechnology.

[9]  J. González,et al.  Transport properties of two finite armchair graphene nanoribbons , 2013, Nanoscale Research Letters.

[10]  Rongfa Guan,et al.  In vitro toxicity of different-sized ZnO nanoparticles in Caco-2 cells , 2013, Nanoscale Research Letters.

[11]  D. Marko,et al.  In vitro toxicity of amorphous silica nanoparticles in human colon carcinoma cells , 2012, Nanotoxicology.

[12]  Claudia Fruijtier-Pölloth.  The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. , 2012, Toxicology.

[13]  A. Elaissari,et al.  Silica-based nanoparticles for biomedical applications. , 2012, Drug discovery today.

[14]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[15]  Solmaz Maleki Dizaj,et al.  Effect of the surface modification, size, and shape on cellular uptake of nanoparticles , 2015, Cell biology international.

[16]  Yuming Cui,et al.  One-pot synthesis of α-Fe2O3 nanospheres by solvothermal method , 2013, Nanoscale Research Letters.

[17]  D. Lambrechts,et al.  Epigenetic effects of carbon nanotubes in human monocytic cells , 2017, Mutagenesis.

[18]  Yunfeng Lin,et al.  The Effect of shape on Cellular Uptake of Gold Nanoparticles in the forms of Stars, Rods, and Triangles , 2017, Scientific Reports.

[19]  Kinam Park,et al.  Effects of the Microparticle Shape on Cellular Uptake. , 2016, Molecular pharmaceutics.

[20]  A. P. Bell,et al.  Proinflammatory Effects of Pyrogenic and Precipitated Amorphous Silica Nanoparticles in Innate Immunity Cells. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  O. Toussaint,et al.  Physicochemical and toxicological evaluation of silica nanoparticles suitable for food and consumer products collected by following the EC recommendation , 2015, Analytical and Bioanalytical Chemistry.

[22]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[23]  Claudia Fruijtier-Pölloth.  The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551) , 2016, Archives of Toxicology.

[24]  Joe Mari Maja,et al.  Applications of nanomaterials in agricultural production and crop protection: A review , 2012 .

[25]  U. Brinkmann,et al.  Effects of Ultrasonic Dispersion Energy on the Preparation of Amorphous SiO2 Nanomaterials for In Vitro Toxicity Testing , 2018, Nanomaterials.

[26]  Laetitia Gonzalez,et al.  Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.

[27]  D. Walter.  Primary Particles – Agglomerates – Aggregates , 2013 .

[28]  Steffen Foss Hansen,et al.  EU Regulation of Nanobiocides: Challenges in Implementing the Biocidal Product Regulation (BPR) , 2016, Nanomaterials.

[29]  Yang Li,et al.  Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  K. Wittmaack.  Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles. , 2011, Chemical research in toxicology.

[31]  Qamar Rahman,et al.  Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. , 2002, Environmental health perspectives.

[32]  M. Kasaai.  Nanosized Particles of Silica and Its Derivatives for Applications in Various Branches of Food and Nutrition Sectors , 2015 .

[33]  Dominique Lison,et al.  The nanosilica hazard: another variable entity , 2010, Particle and Fibre Toxicology.

[34]  Joel M. Cohen,et al.  Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials , 2015, Nanotoxicology.